Targeting the mitogen-activated protein kinase cascade to treat cancer

被引:949
作者
Sebolt-Leopold, JS [1 ]
Herrera, R [1 ]
机构
[1] Pfizer Global Res & Dev, Ann Arbor Labs, Mol Sci & Technol, Ann Arbor, MI 48105 USA
关键词
D O I
10.1038/nrc1503
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The RAS-mitogen activated protein kinase (MAPK) signalling pathway has long been viewed as an attractive pathway for anticancer therapies, based on its central role in regulating the growth and survival of cells from a broad spectrum of human tumours. Small-molecule inhibitors designed to target various steps of this pathway have entered clinical trials. What have we recently learned about their safety and effectiveness? Will the MAPK pathway prove amenable to therapeutic intervention?
引用
收藏
页码:937 / 947
页数:11
相关论文
共 109 条
[11]   Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms [J].
Bonni, A ;
Brunet, A ;
West, AE ;
Datta, SR ;
Takasu, MA ;
Greenberg, ME .
SCIENCE, 1999, 286 (5443) :1358-1362
[12]   Regulation of p21cip1 expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase [J].
Bottazzi, ME ;
Zhu, XY ;
Böhmer, RM ;
Assoian, RK .
JOURNAL OF CELL BIOLOGY, 1999, 146 (06) :1255-1264
[13]  
BRONDELLO JM, 1995, ONCOGENE, V10, P1895
[14]   Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway [J].
Calipel, A ;
Lefevre, G ;
Pouponnot, C ;
Mouriaux, F ;
Eychène, A ;
Mascarelli, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) :42409-42418
[15]  
CARTER C, 2001, P ANN M AM ASS CANC, V42, pA4954
[16]   Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism [J].
Chen, J ;
Fuji, K ;
Zhang, LX ;
Roberts, T ;
Fu, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7783-7788
[17]   Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1) [J].
Cheng, MG ;
Sexl, V ;
Sherr, CJ ;
Roussel, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (03) :1091-1096
[18]   Mechanisms of regulating the Raf kinase family [J].
Chong, H ;
Vikis, HG ;
Guan, KL .
CELLULAR SIGNALLING, 2003, 15 (05) :463-469
[19]   BRAF mutation in papillary thyroid carcinoma [J].
Cohen, J ;
Xing, MZ ;
Mambo, E ;
Guo, ZM ;
Wu, GG ;
Trink, B ;
Beller, U ;
Westra, WH ;
Ladenson, PW ;
Sidransky, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (08) :625-627
[20]  
Cook SJ, 1999, MOL CELL BIOL, V19, P330